Nova Patents
AT355379T

Angiostatin and method of use for inhibition of angiogenesis

Abstract

The invention relates to endothelial cell growth inhibitor and application method. Endothelial cell growth retardant is one of the protein in the blood or salts, wherein said protein wherein the compound is Yifeng from the Slurry opposition high-efficiency liquid chromatography column. Endothelial cell growth retardant is one of a reducing polyacrylamide gel electrophoresis detecting molecular weight of the protein moleculars between about 38 and dalton 45 dalton, and similarly has substantially the starting the mouse plasminogen an amino acid sequence from the group consisting of mice of plasminogen 98 amino acids.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

120 members in 24 offices

This recordMember, by publication datePriority claim14 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
24862994United States of AmericaA
32678594United States of AmericaA

Members120

Family members, oldest first
DocumentOfficeKind
IL113509A0IsraelA0
IL113509D0IsraelD0
CA2188813A1CanadaA1
WO9529242A1World Intellectual Property Organization (WIPO)A1
AU2461795AAustraliaA
WO9530765A1World Intellectual Property Organization (WIPO)A1
ZA953419BSouth AfricaB
NO964598D0NorwayD0
CA2219081A1CanadaA1
WO9635774A2World Intellectual Property Organization (WIPO)A2
AU5579596AAustraliaA
HU9602952D0HungaryD0
WO9635774A3World Intellectual Property Organization (WIPO)A3
EP0758390A1European Patent Office (EPO)A1
EP0758399A1European Patent Office (EPO)A1
CN1149319AChinaA
CZ312296A3CzechiaA3
US5639725AUnited States of AmericaA
HUT76095AHungaryA
MX9605109AMexicoA
BR9507479ABrazilA
NO974943D0NorwayD0
JPH09512173AJapanA
NO974943LNorwayL
MX9708217AMexicoA
JPH10500210AJapanA
EP0824546A2European Patent Office (EPO)A2
NZ285501ANew ZealandA
PL323256A1PolandA1
US5733876AUnited States of AmericaA
CZ334097A3CzechiaA3
AU692865B2AustraliaB2
US5776704AUnited States of AmericaA
HU9800784A2HungaryA2
HUP9800784A2HungaryA2
US5792845AUnited States of AmericaA
HK1002457AHong Kong, ChinaA
HK1002457A1Hong Kong, ChinaA1
CN1195375AChinaA
US5837682AUnited States of AmericaA
CA2291892A1CanadaA1
WO9854217A1World Intellectual Property Organization (WIPO)A1
AU7704998AAustraliaA
US5861372AUnited States of AmericaA
KR19990008029ARepublic of KoreaA
US5885795AUnited States of AmericaA
EP0758399A4European Patent Office (EPO)A4
JPH11508228AJapanA
US5945403AUnited States of AmericaA
AU709633B2AustraliaB2
US6024688AUnited States of AmericaA
BR9608326ABrazilA
NZ332903ANew ZealandA
EP0996632A1European Patent Office (EPO)A1
HU9800784A3HungaryA3
HUP9800784A3HungaryA3
US6190872B1United States of AmericaB1
KR20010020458ARepublic of KoreaA
JP2001506506AJapanA
JP2001151691AJapanA
US2001029246A1United States of AmericaA1
AU744671B2AustraliaB2
NZ307044ANew ZealandA
US2002037847A1United States of AmericaA1
RU2000123250ARussian FederationA
US2002150957A1United States of AmericaA1
US2002164717A1United States of AmericaA1
KR100336452B1Republic of KoreaB1
US6521439B2United States of AmericaB2
US2003064926A1United States of AmericaA1
US2003211518A1United States of AmericaA1
US2004002459A1United States of AmericaA1
US2004023877A1United States of AmericaA1
CA2219081CCanadaC
EP0996632A4European Patent Office (EPO)A4
JP2005046148AJapanA
CN1636594AChinaA
US6949511B1United States of AmericaB1
IL113509AIsraelA
AT355379TThis recordAustriaT
ATE355379T1AustriaT1
CA2291892CCanadaC
JP3787157B2JapanB2
JP2006213724AJapanA
JP3880064B2JapanB2
JP3880593B2JapanB2
EP0758390B1European Patent Office (EPO)B1
CN1309833CChinaC
DE69535405D1GermanyD1
EP1783215A1European Patent Office (EPO)A1
EP0824546B1European Patent Office (EPO)B1
AT368051TAustriaT
ATE368051T1AustriaT1
DE69637179D1GermanyD1
DE69535405T2GermanyT2
US7297546B2United States of AmericaB2
EP1867721A1European Patent Office (EPO)A1
ES2292174T3SpainT3
US2008076113A1United States of AmericaA1
DE69637179T2GermanyT2
Showing 100 of 120